Enacted Stigma From Family and Drug Use During Opioid Use Disorder Treatment

被引:3
|
作者
Earnshaw, Valerie A. [1 ]
Brousseau, Natalie M. [2 ]
Hill, E. Carly [1 ]
Laurenceau, Jean-Philippe [3 ]
Sepucha, Karen R. [4 ,5 ]
Qiu, Xueli [1 ]
Mousavi, Mohammad [1 ]
Morrison, Lynn M. [6 ]
Kelly, John F. [5 ,7 ]
机构
[1] Univ Delaware, Dept Human Dev & Family Sci, 111 Alison Hall West, Newark, DE 19716 USA
[2] Rutgers State Univ, Grad Sch Appl & Profess Psychol, Piscataway, NJ USA
[3] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE USA
[4] Massachusetts Gen Hosp, Hlth Decis Sci Ctr, Boston, MA USA
[5] Harvard Univ, Harvard Med Sch, Cambridge, MA USA
[6] Brandywine Counseling & Community Serv, Wilmington, DE USA
[7] Massachusetts Gen Hosp, Recovery Res Inst, Boston, MA USA
关键词
discrimination; family; opioids; stigma; SUBSTANCE USE DISORDERS; RELIABILITY; VALIDITY; SCALE;
D O I
10.1037/sah0000510
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Enacted stigma (i.e., experiences of discrimination from others) is associated with engagement in drug use among people with a wide range of stigmatized statuses. This association may be particularly concerning among people receiving treatment for opioid use disorder (OUD), among whom continued drug use may undermine treatment outcomes and increase risk of overdose. Although past research largely overlooks the source of enacted stigma, theory and qualitative findings suggest that stigma from family members may be particularly harmful. The present study therefore explores whether enacted stigma experienced from family members is associated with greater engagement in drug use than stigma from other sources among people engaged in OUD treatment. Quantitative data were collected from n = 145 people receiving treatment for OUD. Participants reported on experiences of enacted stigma from a total of k = 190 other people. Drug use was indicated by positive urinalysis test screens. Data were analyzed using general linear mixed models. Results suggest that enacted stigma from family members is more strongly associated with drug use among people engaged in OUD treatment than enacted stigma from other sources. Future research should continue to explore the role of different types of relationships in associations between enacted stigma and drug use, especially among people engaged in OUD treatment. If findings are replicated, interventions should seek to address stigma from family in particular to promote the recovery efforts of people with OUD.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Stigma associated with medication treatment for young adults with opioid use disorder: a case series
    Scott E. Hadland
    Tae Woo Park
    Sarah M. Bagley
    Addiction Science & Clinical Practice, 13
  • [22] Stigma and Medication for Opioid Use Disorder (MOUD) Among Women
    Chou, Jessica L.
    Patton, Rikki
    Cooper-Sadlo, Shannon
    Swan, Carsen
    Bennett, David S.
    McDowell, Dara
    Zaarur, Asif
    Schindler, Barbara
    INTERNATIONAL JOURNAL OF MENTAL HEALTH AND ADDICTION, 2022, 20 (06) : 3262 - 3273
  • [23] Variation in intervention stigma among medications for opioid use disorder
    Madden, Erin F.
    Barker, Kristin K.
    Guerra, Joshua
    Villanueva, Corey
    Sulzer, Sandra H.
    SSM-QUALITATIVE RESEARCH IN HEALTH, 2022, 2
  • [24] Screen of drug use: Diagnostic accuracy for opioid use disorder
    Tiet, Quyen Q.
    Leyva, Yani E.
    Moos, Rudolf H.
    DRUG AND ALCOHOL DEPENDENCE, 2019, 198 : 176 - 179
  • [25] Urine Drug Screening in a Telehealth Setting for the Treatment of Opioid Use Disorder
    Williams, Arthur Robin
    Rowe, Christopher
    Gallagher, Ryan
    Aronowitz, Shoshana V.
    Diamond-Reivich, Jon
    Bisaga, Adam
    JAMA HEALTH FORUM, 2023, 4 (07):
  • [26] Stigma and Medication for Opioid Use Disorder (MOUD) Among Women
    Jessica L. Chou
    Rikki Patton
    Shannon Cooper-Sadlo
    Carsen Swan
    David S. Bennett
    Dara McDowell
    Asif Zaarur
    Barbara Schindler
    International Journal of Mental Health and Addiction, 2022, 20 : 3262 - 3273
  • [27] Nutritional Implications of Opioid Use Disorder: A Guide for Drug Treatment Providers
    Chavez, Melody N.
    Rigg, Khary K.
    PSYCHOLOGY OF ADDICTIVE BEHAVIORS, 2020, 34 (06) : 699 - 707
  • [28] ITI-333: An Investigational Drug for the Treatment of Opioid Use Disorder
    Vanover, Kimberly
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 51 - 52
  • [29] Opioid Use Disorder During Pregnancy
    Kuehn, Bridget
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (12): : 1232 - 1232
  • [30] Opioid Use Disorder During Breastfeeding
    Anderson, Philip O. O.
    BREASTFEEDING MEDICINE, 2023, 18 (06) : 410 - 412